EMAIL THIS PAGE TO A FRIEND

Investigational new drugs

Bisantrene in advanced, hormone-resistant carcinoma of the prostate: an Illinois Cancer Council phase II study.


PMID 2272771

Abstract

We're sorry this abstract is currently not available.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

B4563
Bisantrene dihydrochloride, ≥98% (HPLC)
C22H22N8 ·2HCl